Canada Life’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$912K Hold
25,783
﹤0.01% 1381
2025
Q4
$1.05M Hold
25,783
﹤0.01% 1375
2025
Q3
$1.18M Hold
25,783
﹤0.01% 1393
2025
Q2
$1.34M Buy
25,783
+107
+0.4% +$5.87K ﹤0.01% 1337
2025
Q1
$1.55M Sell
25,676
-3,486
-12% -$225K ﹤0.01% 1291
2024
Q4
$2M Sell
29,162
-270
-0.9% -$18.8K ﹤0.01% 1269
2024
Q3
$2.12M Sell
29,432
-1,555
-5% -$110K ﹤0.01% 1276
2024
Q2
$2.15M Buy
30,987
+4,317
+16% +$315K ﹤0.01% 1257
2024
Q1
$2.13M Sell
26,670
-3,134
-11% -$279K ﹤0.01% 1221
2023
Q4
$3.26M Sell
29,804
-1,013
-3% -$105K 0.01% 989
2023
Q3
$3.11M Sell
30,817
-361
-1% -$41.5K 0.01% 963
2023
Q2
$4.24M Buy
31,178
+2,167
+7% +$265K 0.01% 800
2023
Q1
$3.01M Sell
29,011
-1,870
-6% -$181K 0.01% 1018
2022
Q4
$2.74M Sell
30,881
-2,692
-8% -$223K 0.01% 1056
2022
Q3
$2.69M Buy
33,573
+4,574
+16% +$431K 0.01% 1006
2022
Q2
$2.78M Buy
28,999
+3,780
+15% +$454K 0.01% 986
2022
Q1
$3.84M Buy
25,219
+96
+0.4% +$13.4K 0.01% 864
2021
Q4
$3.56M Sell
25,123
-46
-0.2% -$6.51K 0.01% 886
2021
Q3
$3.32M Buy
25,169
+148
+0.6% +$19.4K 0.01% 870
2021
Q2
$3.44M Buy
25,021
+191
+0.8% +$26.1K 0.01% 834
2021
Q1
$3.24M Sell
24,830
-3,098
-11% -$373K 0.01% 848
2020
Q4
$3.13M Sell
27,928
-4,061
-13% -$385K 0.01% 928
2020
Q3
$2.52M Sell
31,989
-3,360
-10% -$274K 0.01% 954
2020
Q2
$2.54M Sell
35,349
-2,204
-6% -$153K 0.01% 958
2020
Q1
$2.14M Buy
37,553
+2,630
+8% +$243K 0.01% 912
2019
Q4
$3.87M Buy
+34,923
New +$3.72M 0.01% 800
2019
Q3
Sell
-35,837
Closed -$3.06M 1360
2019
Q2
$3.06M Buy
35,837
+109
+0.3% +$8.96K 0.01% 944
2019
Q1
$2.97M Buy
35,728
+699
+2% +$50.8K 0.01% 837
2018
Q4
$2.08M Buy
35,029
+2,965
+9% +$203K 0.01% 983
2018
Q3
$2.54M Buy
32,064
+18
+0.1% +$1.39K 0.01% 1009
2018
Q2
$2.35M Sell
32,046
-2,052
-6% -$140K 0.01% 1072
2018
Q1
$2.16M Buy
34,098
+410
+1% +$24.5K 0.01% 1102
2017
Q4
$1.72M Sell
33,688
-950
-3% -$49.5K ﹤0.01% 1269
2017
Q3
$1.82M Sell
34,638
-2,574
-7% -$129K ﹤0.01% 1222
2017
Q2
$1.9M Buy
37,212
+2,091
+6% +$103K 0.01% 1191
2017
Q1
$1.56M Buy
35,121
+1,804
+5% +$77.6K ﹤0.01% 1280
2016
Q4
$1.47M Sell
33,317
-898
-3% -$38.2K ﹤0.01% 1280
2016
Q3
$1.37M Sell
34,215
-143
-0.4% -$6.07K ﹤0.01% 1286
2016
Q2
$1.64M Buy
34,358
+30,760
+855% +$1.3M ﹤0.01% 1144
2016
Q1
$151K Hold
3,598
﹤0.01% 1487
2015
Q4
$159K Hold
3,598
﹤0.01% 1428
2015
Q3
$172K Hold
3,598
﹤0.01% 1339
2015
Q2
$209K Hold
3,598
﹤0.01% 1348
2015
Q1
$181K Hold
3,598
﹤0.01% 1395
2014
Q4
$161K Hold
3,598
﹤0.01% 1428
2014
Q3
$133K Buy
3,598
+2,246
+166% +$89.1K ﹤0.01% 1460
2014
Q2
$59K Hold
1,352
﹤0.01% 1867
2014
Q1
$58K Hold
1,352
﹤0.01% 1701
2013
Q4
$58K Buy
+1,352
New +$51.4K ﹤0.01% 1693

Other funds holding CNMD

Canada Life's CNMD Position: Q1 2026 in Review

Canada Life held its CONMED (CNMD) position steady in Q1 2026 at 25,783 shares worth $912K. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

Canada Life first reported a position in CNMD in Q4 2013 and has held it in 49 quarters since. The position peaked at $4.24M in Q2 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Canada Life held 25,783 shares of CONMED worth $912K as of Q1 2026.
  • Canada Life left its CONMED share count unchanged in Q1 2026.
  • CONMED made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1381 holding.
  • Canada Life first reported a position in CONMED in Q4 2013 and has held it in 49 quarters since.
  • Canada Life's CONMED position peaked at $4.24M in Q2 2023.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.